Expression of EpCAM Increases in the Hepatitis B Related and the Treatment-Resistant Hepatocellular Carcinoma
Figure 4
(a) Frequency of EpCAM expression in nontreated regions and posttreatment regions (TACE and HAIC). (b) Immunohistochemical staining of EpCAM in resected HCCs previously treated.
